A Never Seen Versatility
We have completely reengineered our Nu.Q™ Clinical Assays and I am delighted to say that our platform has been fully optimized and is now finalized. This Optimization Program led to a step-change improvement in analytical performance and, as importantly, made our assays very robust and reproducible, so that they can be adapted to a broad range of platforms suitable for almost any lab in the world.
